Conclusion of a non-exclusive rebate agreement pursuant to Section 130a(8) of the German Social Code Book V for the active substance Bimatoprost (only in the strength 0.1 mg/ml), ATC S01EE03, for the period 01/06/2026–31/05/2028 (plus option to extend once by 12 months)

Summary

The tender concerns a non-exclusive rebate agreement for medicines containing Bimatoprost, valid from 1 June 2026 to 31 May 2028, with an option to extend once by 12 months. It is an open accession model: any interested pharmaceutical company may join the agreement if it submits the required documents on time by email. No tender guarantee is required, and participation is open to all interested pharmaceutical companies that meet the conditions in the tender documents.